<p>NanoViricides Inc. held its annual meeting of stockholders on November 22, 2025. Shareholders approved the re-election of Anil Diwan as a director. The advisory vote on executive compensation was also approved. In addition, the appointment of EisnerAmper, LLP as the independent registered public accounting firm for the fiscal year ending June 30, 2026 was ratified. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NanoViricides Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-116457), on November 26, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

NNVC

<p>NanoViricides Inc. held its annual shareholder meeting on November 22, 2025. Shareholders re-elected Anil Diwan as director, approved executive compensation, and ratified EisnerAmper, LLP as the accounting firm for fiscal year ending June 30, 2026.</p>

NanoViricides Inc. Held Annual Shareholder Meeting